Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Scott Koenig

Showing results (21-30 of 54) with videos related to

Pageof 6
Sort By:
The Journal of Knee Surgery|September 8, 2020
Predictors of PROMIS Physical Function at 2 Years following Knee SurgeryDarius Hunt, Tina Zhang, Scott Koenig, et al.
Global Spine Journal|April 16, 2019
Can Liposomal Bupivacaine Be Safely Utilized in Elective Spine Surgery?Luke Brown, Tristan Weir, Scott Koenig, et al.
Advances in Enzyme Regulation|January 8, 2008
Enhancing the potency of therapeutic monoclonal antibodies via Fc optimizationJeffrey B Stavenhagen, Sergey Gorlatov, Nadine Tuaillon, et al.
Journal of Clinical Orthopaedics and Trauma|July 19, 2021
Predictors of two-year patient satisfaction following elective knee surgeryJustin E Kung, Tina Zhang, Ali Aneizi, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 11, 2005
Selective blockade of inhibitory Fcgamma receptor enables human dendritic cell maturation with IL-12p70 production and immunity to antibody-coated tumor cellsKavita M Dhodapkar, Jacob L Kaufman, Marc Ehlers, et al.
Cancer Research|September 19, 2007
Fc optimization of therapeutic antibodies enhances their ability to kill tumor cells in vitro and controls tumor expansion in vivo via low-affinity activating Fcgamma receptorsJeffrey B Stavenhagen, Sergey Gorlatov, Nadine Tuaillon, et al.
Antimicrobial Agents and Chemotherapy|March 31, 2010
Safety and pharmacokinetics of single intravenous dose of MGAWN1, a novel monoclonal antibody to West Nile virusJohn H Beigel, Jeffrey L Nordstrom, Stanley R Pillemer, et al.
The Journal of Infectious Diseases|October 17, 2006
Humanized monoclonal antibody against West Nile virus envelope protein administered after neuronal infection protects against lethal encephalitis in hamstersJohn D Morrey, Venkatraman Siddharthan, Aaron L Olsen, et al.
Diabetes|June 27, 2013
Teplizumab preserves C-peptide in recent-onset type 1 diabetes: two-year results from the randomized, placebo-controlled Protégé trialWilliam Hagopian, Robert J Ferry, Nicole Sherry, et al.
Journal of Neurovirology|April 30, 2008
West Nile virus-induced acute flaccid paralysis is prevented by monoclonal antibody treatment when administered after infection of spinal cord neuronsJohn D Morrey, Venkatraman Siddharthan, Hong Wang, et al.
Pageof 6

Showing results (21-30 of 54) with videos related to

Sort By:
Pageof 6
The Journal of Knee Surgery|September 8, 2020
Predictors of PROMIS Physical Function at 2 Years following Knee SurgeryDarius Hunt, Tina Zhang, Scott Koenig, et al.
Global Spine Journal|April 16, 2019
Can Liposomal Bupivacaine Be Safely Utilized in Elective Spine Surgery?Luke Brown, Tristan Weir, Scott Koenig, et al.
Advances in Enzyme Regulation|January 8, 2008
Enhancing the potency of therapeutic monoclonal antibodies via Fc optimizationJeffrey B Stavenhagen, Sergey Gorlatov, Nadine Tuaillon, et al.
Journal of Clinical Orthopaedics and Trauma|July 19, 2021
Predictors of two-year patient satisfaction following elective knee surgeryJustin E Kung, Tina Zhang, Ali Aneizi, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 11, 2005
Selective blockade of inhibitory Fcgamma receptor enables human dendritic cell maturation with IL-12p70 production and immunity to antibody-coated tumor cellsKavita M Dhodapkar, Jacob L Kaufman, Marc Ehlers, et al.
Cancer Research|September 19, 2007
Fc optimization of therapeutic antibodies enhances their ability to kill tumor cells in vitro and controls tumor expansion in vivo via low-affinity activating Fcgamma receptorsJeffrey B Stavenhagen, Sergey Gorlatov, Nadine Tuaillon, et al.
Antimicrobial Agents and Chemotherapy|March 31, 2010
Safety and pharmacokinetics of single intravenous dose of MGAWN1, a novel monoclonal antibody to West Nile virusJohn H Beigel, Jeffrey L Nordstrom, Stanley R Pillemer, et al.
The Journal of Infectious Diseases|October 17, 2006
Humanized monoclonal antibody against West Nile virus envelope protein administered after neuronal infection protects against lethal encephalitis in hamstersJohn D Morrey, Venkatraman Siddharthan, Aaron L Olsen, et al.
Diabetes|June 27, 2013
Teplizumab preserves C-peptide in recent-onset type 1 diabetes: two-year results from the randomized, placebo-controlled Protégé trialWilliam Hagopian, Robert J Ferry, Nicole Sherry, et al.
Journal of Neurovirology|April 30, 2008
West Nile virus-induced acute flaccid paralysis is prevented by monoclonal antibody treatment when administered after infection of spinal cord neuronsJohn D Morrey, Venkatraman Siddharthan, Hong Wang, et al.
Pageof 6